New York State Common Retirement Fund’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-40
| Closed | -$573 | – | 3285 |
|
|
2024
Q2 | $573 | Sell |
40
-1,927
| -98% | -$32.1K | ﹤0.01% | 3325 |
|
|
2024
Q1 | $30.4K | Buy |
1,967
+27
| +1% | +$582 | ﹤0.01% | 3088 |
|
|
2023
Q4 | $54.3K | Sell |
1,940
-15
| -0.8% | -$394 | ﹤0.01% | 2968 |
|
|
2023
Q3 | $93.1K | Buy |
1,955
+25
| +1% | +$1.91K | ﹤0.01% | 2760 |
|
|
2023
Q2 | $185K | Buy |
1,930
+301
| +18% | +$32.8K | ﹤0.01% | 2531 |
|
|
2023
Q1 | $185K | Sell |
1,629
-825
| -34% | -$89.2K | ﹤0.01% | 2622 |
|
|
2022
Q4 | $275K | Sell |
2,454
-1
| -0% | -$134 | ﹤0.01% | 2583 |
|
|
2022
Q3 | $315K | Buy |
2,455
+5
| +0.2% | +$512 | ﹤0.01% | 2566 |
|
|
2022
Q2 | $168K | Sell |
2,450
-4
| -0.2% | -$345 | ﹤0.01% | 2872 |
|
|
2022
Q1 | $349K | Sell |
2,454
-39
| -2% | -$6K | ﹤0.01% | 2568 |
|
|
2021
Q4 | $415K | Buy |
2,493
+573
| +30% | +$91K | ﹤0.01% | 2537 |
|
|
2021
Q3 | $267K | Sell |
1,920
-1,082
| -36% | -$212K | ﹤0.01% | 2784 |
|
|
2021
Q2 | $1.43M | Buy |
3,002
+437
| +17% | +$184K | ﹤0.01% | 2055 |
|
|
2021
Q1 | $1.06M | Sell |
2,565
-50
| -2% | -$23K | ﹤0.01% | 2105 |
|
|
2020
Q4 | $1.28M | Buy |
2,615
+500
| +24% | +$293K | ﹤0.01% | 1922 |
|
|
2020
Q3 | $1.2M | Buy |
2,115
+100
| +5% | +$33.3K | ﹤0.01% | 1822 |
|
|
2020
Q2 | $192K | Buy |
2,015
+1,050
| +109% | +$92.1K | ﹤0.01% | 2660 |
|
|
2020
Q1 | $69K | Hold |
965
| – | – | ﹤0.01% | 2895 |
|
|
2019
Q4 | $67K | Hold |
965
| – | – | ﹤0.01% | 3089 |
|
|
2019
Q3 | $77K | Hold |
965
| – | – | ﹤0.01% | 3093 |
|
|
2019
Q2 | $62K | Hold |
965
| – | – | ﹤0.01% | 3185 |
|
|
2019
Q1 | $133K | Hold |
965
| – | – | ﹤0.01% | 2875 |
|
|
2018
Q4 | $87K | Hold |
965
| – | – | ﹤0.01% | 2991 |
|
|
2018
Q3 | $146K | Hold |
965
| – | – | ﹤0.01% | 2962 |
|
|
2018
Q2 | $166K | Hold |
965
| – | – | ﹤0.01% | 2964 |
|
|
2018
Q1 | $142K | Sell |
965
-200
| -17% | -$38.4K | ﹤0.01% | 2859 |
|
|
2017
Q4 | $236K | Hold |
1,165
| – | – | ﹤0.01% | 2681 |
|
|
2017
Q3 | $374K | Hold |
1,165
| – | – | ﹤0.01% | 2503 |
|
|
2017
Q2 | $263K | Buy |
1,165
+435
| +60% | +$89.3K | ﹤0.01% | 2708 |
|
|
2017
Q1 | $165K | Hold |
730
| – | – | ﹤0.01% | 2835 |
|
|
2016
Q4 | $145K | Hold |
730
| – | – | ﹤0.01% | 2881 |
|
|
2016
Q3 | $179K | Buy |
730
+285
| +64% | +$100K | ﹤0.01% | 2800 |
|
|
2016
Q2 | $259K | Hold |
445
| – | – | ﹤0.01% | 2601 |
|
|
2016
Q1 | $236K | Buy |
445
+105
| +31% | +$54.8K | ﹤0.01% | 2603 |
|
|
2015
Q4 | $239K | Buy |
+340
| New | +$223K | ﹤0.01% | 2678 |
|
Other funds holding MCRB
FP
SSA
New York State Common Retirement Fund's MCRB Position: Q3 2024 in Review
New York State Common Retirement Fund sold out of Seres Therapeutics (MCRB) in Q3 2024, closing a stake of 40 shares — an estimated $573 sold.
New York State Common Retirement Fund first reported a position in MCRB in Q4 2015 and held it in 35 quarters. The position peaked at $1.43M in Q2 2021. 77 funds tracked by Wall St. Rank hold MCRB as of Q3 2024.
- New York State Common Retirement Fund reported no remaining Seres Therapeutics position as of Q3 2024 after selling out during the quarter.
- New York State Common Retirement Fund sold 40 Seres Therapeutics shares in Q3 2024, an estimated $573.
- New York State Common Retirement Fund first reported a position in Seres Therapeutics in Q4 2015 and held it in 35 quarters.
- New York State Common Retirement Fund's Seres Therapeutics position peaked at $1.43M in Q2 2021.
- 77 funds tracked by Wall St. Rank held Seres Therapeutics as of Q3 2024.
Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.